The measurement of blood component quality

The Speaker

Dana Devine

ISBT Award Winner 2020, Chief Medical & Scientific Officer, Canadian Blood Services, Vancouver, Canada

Dana Devine is currently the Chief Medical & Scientific Officer at Canadian Blood Services. She is also Professor of Pathology and Laboratory Medicine at the University of British Columbia, and a founding member of the University’s Centre for Blood Research. She was the Editor-in-Chief of ISBT's blood transfusion journal Vox Sanguinis. Dr. Devine completed her research training at Duke University in North Carolina where she obtained the Ph.D. degree. She has a longstanding research career in blood products, transfusion medicine, platelet biology, complement biochemistry, and coagulation.

Dana leads the Medical Services & Innovation division at Canadian Blood Services. This includes responsibility for transfusion medicine, donor and transplantation services, emerging pathogens and infectious diseases, surveillance and epidemiology, as well as research and development.

Since joining Canadian Blood Services in 1999 as the executive director of research and development, she has played an integral role in a number of initiatives, particularly the development of the visionary Network Clinic for Advancement and Development Laboratory in Vancouver.

Dana holds a PhD in immunology from Duke University in North Carolina, and has more than 25 years of professional association with the University of British Columbia’s Faculty of Medicine as an educator and mentor in blood research.

The measurement of blood component quality

Related topics

The first 2026 issue of Transfusion Today is live now!

The measurement of blood component quality

Related topics

You may also be interested in

Updated EUROGTP II Interactive Assessment Tool (IAT)

Transfusion Training Hub

CMV seronegative blood components: The past, present and future

Innovative manufacturing techniques for blood components of the future

Repurposing surplus plasma and expired platelets into useful biotherapies

The Role of Leukoreduction in Modern Transfusion Medicine

The first 2026 issue of Transfusion Today is live now!